Shareholder Information

PEL – Board Meeting Intimation – 26th May 2022

Reg. 30 – Composite Scheme of Arrangement – 14th May, 2022

PEL – Allotment of Non-Convertible Debentures – 4th May, 2022

PEL – Outcome of Committee Meeting – 4th May, 2022

PEL – Intimation of Credit Rating – 27th April, 2022

Filing of Company Application for Composite Scheme of Arrangement with NCLT – 27th April, 2022

PEL – Further acquisition of Yapan Bio Private Limited – 4th April, 2022

PEL – Resignation of Mr. Gautam Banerjee as an Independent Director of the Company – 1st April, 2022

PEL – Appointment of Ms. Shikha Sharma as Non-Executive Non – Independent Director – 1st April, 2022

PEL – Allotment of Non-Convertible Debentures – 28th March, 2022

PEL – Outcome of Committee Meeting – 28th March, 2022

PEL – Analyst Meet –22nd March, 2022

PEL – Analyst Meet – 15th March, 2022

PEL – Analyst Meet – 7th March, 2022

PEL – Allotment of Non-Convertible Debentures – 2nd March, 2022

PEL – Outcome of Committee Meeting – 28th February, 2022

PEL – Newspaper Advertisement – Extract of Consolidated Financial Results for the quarter and nine months ended 31st December, 2021

PEL – Auditor’s Report with UDIN for quarter ended 31st December, 2021

PEL – Appointment of Independent Director– 10th February, 2022

PEL – Outcome of the Board Meeting – 10th February, 2022

PEL – Intimation of Conference Call – 10th February, 2022

PEL – Board Meeting Intimation – 10th February, 2022

Press statement issued by Piramal Capital & Housing Finance Limited (formerly known as Dewan Housing Finance Corporation Limited)

PEL – Acquisition of Yapan Bio Private Limited

PEL – Analyst Meet- 12th January, 2022

PEL – Intimation of Resignation of Mr. Rajesh Laddha as Executive Director

PEL – Merger of Shrilekha Business Consultancy Private Limited into Shriram Capital Limited

PEL – Investors Meet – 9th December, 2021

PEL – Analyst Meet – 1st December, 2021

PEL – Newspaper Advertisement – Extract of Consolidated Financial Results for the quarter and half year ended 30th September, 2021

PEL – Analyst Meet – 15th to 19th November, 2021

PEL – Auditor’s Report with UDIN for quarter ended 30th September, 2021

PEL – Outcome of the Board Meeting – 11th November, 2021

PEL – Board Meeting Notice – 11th November, 2021

Appointment of Independent Director – 7th October, 2021

Composite Scheme of Arrangement

PEL – Analyst Meet – 13th & 14th September, 2021

PEL – Statement of deviation(s) or variation(s) for the quarter ended 30th June, 2021

PEL – Transcript of Conference Call – 6th August, 2021

PEL – Intimation of Credit Rating

PEL – Analyst Meet – 12th August, 2021

PEL – Notice of Board Meeting published in Newspapers

PEL – Auditor’s Report with UDIN for quarter ended 30th June, 2021

PEL – Outcome of the Board Meeting – 6th August, 2021

PEL – Resignation of Mr. Deepak Satwalekar as an Independent Director of the Company – 27th July, 2021

PEL – Proceedings and Voting Results of the 74th Annual General Meeting of the Company

PEL – Allotment of equity shares reserved in favour of CCD holders under Rights Issue of the Company

PEL – Newspaper Advertisement – Notice of 74th Annual General Meeting

PEL – Update on acquisition of stake in Hemmo Pharmaceuticals Private Limited– 23rd June, 2021

PEL – Newspaper Advertisement – Information regarding 74th Annual General Meeting (‘AGM’) and Record Date for final dividend

PEL – Intimation of Annual General Meeting and Record Date for payment of final dividend

PEL – Allotment of equity shares pursuant to conversion of Compulsorily Convertible Debentures

PEL – The Hon’ble NCLT approves the resolution plan of PCHFL in relation to CIRP of DHFL – 7th June, 2021

PEL – Analyst Meet – 3rd June, 2021

PEL – Analyst Meet – 2nd & 3rd June, 2021

PEL – Transcript of Conference Call – 13th May, 2021

PEL – Newspaper Advertisement – Extract of Consolidated Financial Results for the three months and year ended 31st March, 2021

PEL – Auditors’ Report with UDIN for the quarter and year ended 31st March, 2021

PEL – Outcome of the Board Meeting – Audited Financial Results & Dividend – 13th May, 2021

PEL – Intimation of Conference Call – 13th May, 2021

PEL – Notice of Board Meeting published in Newspapers

PEL – Board Meeting Notice – 13th May, 2021

PEL – Appointment of Director – 2nd April, 2021

PEL – Presentation on acquisition of Hemmo Pharmaceuticals by Piramal Pharma Limited – 1st April, 2021

PEL – Filing of Draft Shelf Prospectus by PCHFL in connection with a public issue of NCDs – 31st March, 2021

PEL – Acquisition of 100% stake in Hemmo Pharmaceuticals Private Limited by Piramal Pharma Limited – 31st March, 2021

PEL – PCHFL raises INR 4,050 crores via issuance of NCDs – 22nd March, 2021

PEL –Analyst Meet- 22nd March, 2021

PEL – Analyst Meet- 3rd March, 2021

PEL – Analyst Meet- 2nd March, 2021

PEL – Analyst Meet– 26th February, 2021

PEL – Update on acquisition of stake in Convergence Chemicals Private Limited by Piramal Pharma Limited – 24th February, 2021

PEL – Analyst Meet- 25th February, 2021

PEL – Analyst Meet- 22nd & 23rd February, 2021

PEL – Analyst Meet- 18th – 19th February, 2021

PEL – Analyst Meet- 16th February, 2021

PEL – Newspaper Advertisement – Extract of Consolidated Financial Results for the quarter and nine months ended 31st December, 2020

PEL –Analyst Meet- 12th February, 2021

PEL –Analyst Meet- 15th – 17th February, 2021

PEL –Auditors’ Report with UDIN for the quarter and nine months ended 31st December, 2020

PEL – Outcome of the Board Meeting – 11th February, 2021

PEL – Notice of Board Meeting published in Newspapers.

PEL – Board Meeting Notice – 11th February, 2021.

PEL – PCHFL identified as the successful resolution applicant in relation to Corporate Insolvency Resolution Process of DHFL – 22nd January, 2021

PEL – Appointment of Independent Director – 19th November, 2020

PEL – Newspaper Advertisement – Extract of Consolidated Financial Results for the quarter and half year ended 30th September, 2020

PEL – Auditors’ Report with UDIN for the quarter and half year ended 30th September, 2020

PEL – Acquisition of stake in Convergence Chemicals Private Limited by Piramal Pharma Limited – 28th October, 2020

PEL – Resignation of Independent Directors – 28th October, 2020

PEL – Outcome of the Board Meeting – 28th October, 2020

PEL – Notice of Board Meeting published in Newspapers

PEL – Board Meeting Notice- 28th October, 2020

PEL – Appointment of Independent Directors – 15th October, 2020

PEL – Completion of transfer of Pharma Business and 20% Strategic Growth Investment by Carlyle – 6th October, 2020

PEL – Analyst Meet – 9th & 10th September, 2020

PEL – Analyst Meet – 31st August, 2020

PEL – Analyst Meet – 24th August, 2020

PEL – Analyst Meet – 17th August, 2020

PEL – Newspaper Advertisement – Extract of Consolidated Financial Results for the quarter ended 30th June, 2020

PEL – Scrutinizer’s Report for Annual General Meeting for FY 2019-2020

PEL – Proceedings of the 73rd Annual General Meeting – 30th July, 2020

PEL – Auditors’ Report with UDIN for the quarter ended 30th June, 2020

PEL – Outcome of the Board Meeting – 30th July, 2020

PEL – Analyst Meet – 28th July, 2020

PEL – Notice of Board Meeting published in Newspapers.

PEL – Board Meeting Notice – 30th July, 2020

PEL – Newspaper Advertisement for Notice of 73rd Annual General Meeting.

PEL – Newspaper Advertisement – Information regarding 73rd Annual General Meeting (‘AGM’) and Book Closure.

PEL – Carlyle and Piramal Pharma Sign Agreement on a 20% Strategic Growth Investment

PEL – Update on acquisition of G&W Laboratories Inc.

PEL – Acquisition of Solid Oral Dosage Drug Product Facility in Sellersville, Pennsylvania from G&W Laboratories Inc.

PEL –Auditors’ Report with UDIN for the quarter and financial year ended 31st March, 2020

Outcome of the Board Meeting – Audited Financial Results – 11th May, 2020

Outcome of the Board Meeting – 11th May, 2020

PEL – Board Meeting Notice – 11th May, 2020

PEL – Analyst Meet – 8th May, 2020

CARE Credit Rating – 22nd April, 2020

PEL – Intimation of Credit Rating

PEL – Intimation to consider Interim Dividend

PEL – Update on Divestment of stake in DRG Business – 2nd March, 2020

PEL – Outcome of the Board Meeting – 4th February, 2020

PEL – Outcome of Committee Meeting – 29th January, 2020

PEL- Board Meeting Notice- 4th February, 2020

PEL – Divestment of stake in DRG Business – 17th January, 2020

Proceedings of the Extraordinary General Meeting – 25th November, 2019

Scrutinizer’s report for Extraordinary General Meeting – 25th November, 2019

PEL – Limited Review Report for the quarter ended 30th September, 2019

PEL – Board Meeting Notice – 21st October, 2019

PEL Files Complaint with SEBI regarding misleading rumors about the Company

PEL- Outcome of Committee Meeting – 13th September, 2019

PEL-Analyst Meet- 11rd September, 2019 & 12th September,2019

PEL-Analyst Meet- 11th September, 2019 & 12th September,2019

Outcome of Committee Meeting – 28th August, 2019

PEL-Analyst Meet- 3rd September, 2019 & 4th September,2019

PEL-Analyst Meet-19th August, 2019

Proceeding of the 72nd Annual General Meeting – 30th July,2019

PEL-Analyst Meet-29th August, 2019 & 30th August,2019

Scrutinizer’s Report for Annual General Meeting for FY 2018-2019

PEL – Board Meeting Notice -30th July, 2019

PEL – Intimation of Conference Call – 30th June, 2019

PEL – Outcome of Committee Meeting – 12th July, 2019

PEL – Outcome of Committee Meeting – 10th July, 2019

PEL – Outcome of Committee Meeting – 12th June, 2019

PEL – Outcome of Committee Meeting – 11th June, 2019

PEL – Analyst Meet – 7th June, 2019

PEL – Analyst Meet – 12th June, 2019

PEL – Analyst Meet – 5th June, 2019

PEL – Analyst Meet – 3rd June, 2019

PEL – Allotment of Shares out of CCD Reservation portion – 30th May, 2019

PEL – Analyst Meet – 29th May, 2019

PEL– Allotment of shares out of CCD Reservation portion – 21st May, 2019

PEL- Extract of Audited Financial Results for the quarter / year ended March 31, 2019 published in newspapers – English – Business Standard and Marathi-Mumbai Lakshadeep

PEL- Notice of Board Meeting published in newspapers – English –The Free Press Journal and Marathi-Navshakti

PEL – Updates

PEL – Analyst Meet – 13th – 16th May, 2019

PEL – Analyst Meet – 8th – 10th May, 2019

PEL – Outcome of the Board Meeting – 26th April, 2019

PEL – Analyst Meet – 22nd April, 2019

PEL Allotment of Shares pursuant to Conversion of CCD’s – 22nd April, 2019

PEL – Board Meeting Notice – 26th April, 2019

PEL – Allotment of shares out of CCD Reservation portion – 5th April, 2019

PEL – Allotment of shares Pursuant to CCD Conversion – 11th April, 2019

Record date for conversion of CCDs

PEL – Intimation of Record Date for CCD

PEL – Outcome of the Meeting of the Committee of Directors (Rights Issue) – 19th March, 2019

PEL – Outcome of the Committee Meeting – 14th March, 2019

PEL – Analyst Meet – 18th – 19th March, 2019

PEL – Press Release – Piramal Announces the Launch of Cinacalcet by its Partner, Slate Run Pharmaceuticals, in the U.S. – 12th March, 2019

PEL – Press Release – Piramal Critical Care announces the U.S. launch of MITIGO – 11th March, 2019

PEL – Press Release – Supreme Court Exempts Saridon from the List of Banned FDCs – 21st February, 2019

PEL – Analyst Meet – 4th March, 2019

PEL – Analyst Presentation

PEL – Analyst Meet – 18th February, 2019

PEL – Analyst Meet – 15th February, 2019

PEL – Analyst Meet – 14th February, 2019

Outcome of Committee Meeting – 12th February, 2019

PEL – Analyst Meet – 11th, 12th & 13th February, 2019

Outcome of Committee Meeting – 4th February, 2019

PEL – Transcript of Analyst Conference call – 28th January, 2019

PEL – Intimation of Conference call – 28th January, 2019

PEL – Board Meeting Notice – 28th January, 2019

Outcome of Committee Meeting – 16th January, 2019

PEL – Outcome of the Committee Meeting -2nd January, 2019

Outcome of Committee Meeting – 27th December, 2018

Outcome of Committee Meeting – 21st December, 2018

Outcome of Committee Meeting – 24th December, 2018

PEL – Intimation of Credit Rating

Outcome of Committee Meeting – 18th December, 2018

Outcome of Committee Meeting – 29th November, 2018

Outcome of Committee Meeting – 28th November, 2018

PEL – Analyst Meet – 28th November, 2018

Outcome of Committee Meeting – 22nd November, 2018

PEL – Analyst Meet – 22nd November, 2018

Outcome of Committee Meeting – 21st November, 2018

Outcome of Committee Meeting – 16th November, 2018

Outcome of Committee Meeting – 15th November, 2018

PEL – Analyst Meet – 15th November, 2018

PEL – Outcome of Committee Meeting – 13th November, 2018

PEL – Analyst Meet – 13th November, 2018

PEL – Outcome of the Board Meeting – 25th October, 2018

PEL – Transcript of Analyst Conference Call – 25th October, 2018

PEL – Outcome of Committee Meeting

PEL – Appointment of Director – 25th October, 2018

PEL – Intimation of Conference Call – 25th October, 2018

PEL – Outcome of the Committee Meeting – 5th October, 2018

PEL – Outcome of the Committee Meeting – 25th September, 2018

PEL Analysts / Institutional Investors Meeting Update – 24th September, 2018

PEL – Intimation of Credit Rating

PEL – Allotment of shares out of CCD Reservation portion – 17th September, 2018

PEL – Analyst Presentation – 30th August, 2018

PEL – Outcome of the Committee Meeting – 7th September, 2018

PEL – Analyst Meeting – 3rd September, 2018

PEL – Outcome of the Committee Meeting – 31st August, 2018

PEL – Analyst Meeting – 30th August, 2018

Transfer of shares in Demat Form

PEL – Transcript of Analyst Conference Call – 30th July, 2018

PEL – Analysts Meeting – 9th August, 2018

Scrutinizer’s Report for Annual General Meeting for FY 2017-18

Proceedings of the 71st Annual General Meeting – 30th July, 2018

PEL – Outcome of the Board Meeting – 30th July, 2018

PEL – Intimation of Conference Call – 30th July, 2018

PEL – Board Meeting Notice – 30th July, 2018

PEL – Allotment of shares out of CCD reservation portion

PEL – Newspaper’s AGM Notice

PEL – Divestment of stake in Piramal Imaging SA (PISA) – 26th June, 2018

PEL – Intimation of Analyst Meet- 7th June, 2018

PEL – Intimation of Analyst Meet – 5th June, 2018

PEL – Outcome of the Board Meeting – 28th May, 2018

PEL – Board Meeting Notice – 28th May, 2018

PEL – Outcome of the Committee Meeting – 15th May, 2018

PEL – Outcome of the Committee Meeting – 7th May, 2018

PEL – Shareholding Pattern (Post Allotment) – 8th March, 2018

PEL – Intimation of the Analyst Meet – 23rd March, 2018

PEL – Outcome of the Administrative Committee Meeting – 21st March, 2018

PEL – Outcome of the Meeting of the Committee of Directors (Rights Issue) – 8th March, 2018

PEL – Analyst Meet – 5th March, 2018

PEL – Outcome of the Committee Meeting – 12th February, 2018

PEL – Analyst Meet – 21st February, 2018

PEL – Analyst Meet – 8th February, 2018

PEL – Outcome of the Committee Meeting – 31st January, 2018

PEL – Outcome of the Board Meeting – 30th January, 2018

PEL – Board Meeting Notice – 30th January, 2018

Clarification in relation to Stock exchange intimation dated January 19, 2018

PEL – Outcome of Committee Meeting – 19th January, 2017

Timeline for conversion of CCDs into Equity Shares

PEL – Board Meeting Notice – 6th November, 2017

Piramal Enterprises QIP PD

Piramal Enterprises QIP PPD

PEL – Joint Venture with Bain Capital – 19th July, 2017

Proceedings of the 70th Annual General Meeting – 1st August, 2017

PEL – Chief Financial Officer – 28th June, 2017

PEL – Board Meeting Notice – 12th May, 2017

PEL – Outcome of the Board Meeting – 12th May, 2017

Press Release – Piramal Enterprises Completes the Acquisition of a Portfolio of Drugs for Spasticity and Pain Management from Mallinckrodt LLC – 20th March, 2017

Change in Registered Office & Mumbai operation of the Registrar & Share Transfer Agent of the Company – 28th February, 2017

PEL – Investor/ Analyst Conference – 27th February, 2017 to 6th March, 2017

PEL – Analysts Meeting – 22nd February, 2017

PEL – Analyst Meeting – 14th February, 2017

PEL – Outcome of Board Meeting – 13th February, 2017

PEL – Transcript of Analyst Conference Call – 31st January, 2017

PEL – Board Meeting Notice – 13th February, 2017

PEL – Analyst Presentation – 31st January, 2017

PEL – Analyst Conference Call – 31st January, 2017

Press Release – Piramal Enterprises announces Acquisition of a Portfolio of Drugs for Spasticity and Pain Management from Mallinckrodt LLC. – 30th January, 2017

PEL Outcome of Board Meeting – 5th January 2017

News Clarification – 28th December, 2016

PEL – Transcript of Analyst Conference Call – 22nd November, 2016

Press Release – Piramal Enterprises Limited announces its plan to enter housing finance – 5th January, 2017

PEL – Analyst Conference Call – 21st November, 2016

PEL – Analysts Meeting – 7th November, 2016 to 11th November, 2016

PEL – Board Meeting Notice – 27th October, 2016

Press Release – Agreement to acquire Janssen’s injectable anesthesia and pain management products by wholly-owned subsidiary. – 10th October, 2016

PEL – Stock Exchange Intimation for the Committee on 10th October, 2016

PEL – Outcome of Committee Meeting on 30th September, 2016

PEL – Stock Exchange Intimation for the Committee meeting on 30th September, 2016

PEL – Stock Exchange Intimation – 20th September, 2016 – Sell Down

PEL – Analysts Meet – 9th September, 2016

PEL – Analysts Meet – 30th August, 2016

News Clarification – 28th August, 2016

Stock Exchange Intimation for the Committee Meeting on 25th August, 2016

Stock Exchange intimation for the Committee Meeting on 11th August, 2016

Proceedings of the 69th Annual General Meeting – 1st August, 2016

PEL – Outcome of Annual General Meeting – 1st August, 2016

PEL – Board Meeting Notice – 1st August, 2016

PEL – Advertisement of Annual General Meeting – 1st August, 2016 – English

PEL – Advertisement of Annual General Meeting – 1st August, 2016 – Marathi

PEL – Analysts Meet – 27th June, 2016

PEL – Analysts Meet – 7th June, 2016

PEL – Board Meeting Notice – 16th May, 2016

Press Release – Agreement to acquire brands from Pfizer Limited – 13th May, 2016

PEL – Analysts Meet – 12th April, 2016

PEL – Analysts Meet – 29th March, 2016

Other Corporate Updates – 23rd March, 2016

PEL – Outcome of Committee Meeting held on 18th March, 2016

PEL – Outcome of Board Meeting held on 9th March, 2016

PEL – Analyst Meets 03rd March, 2016

PEL – Press Release Adaptive Acqn by DRG

PEL – Analyst Meets 15th February, 2016

PEL – KMP’s for determining materiality – 8th February, 2016

PEL – Board meeting notice – 1st February, 2016